Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 193-198

  Zhou, Lu ^a   Park, Byung Hyun ^b   Park, Jong Hyuk ^a   Jang, Kyu Yun ^a   Park, Ho Sung ^a   Wagle, Sajeev ^a   Lee, Kwang Bok ^a   Kim, Jung Ryul ^a  

^a Chonbuk National University   (South Korea)

^b Departments of Biochemistry   (South Korea)

Author keywords

Cell cycle; Cyclin D1; Osteosarcoma; PIN1; Proliferation

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; JUGLONE; PEPTIDYLPROLYL ISOMERASE PIN1;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OSTEOSARCOMA; OSTEOSARCOMA CELL; PIN GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; BONE AND BONES; BONE NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; IMMUNOENZYME TECHNIQUES; OSTEOSARCOMA; PEPTIDYLPROLYL ISOMERASE; TUMOR CELLS, CULTURED;

EID: 84872852979     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2112     Document Type: Article

References (33)

1. Galat A: Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity - targets - functions. Curr Top Med Chem 3: 1315-1347, 2003.
2. Lu KP, Suizu F, Zhou XZ, Finn G, Lam P and Wulf G: Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol Carcinog 45: 397-402, 2006.
3. Lu KP, Hanes SD and Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547, 1996.
4. Blume-Jensen P and Hunter T: Oncogenic kinase signalling. Nature 411: 355-365, 2001.
5. Hunter T: Prolyl isomerases and nuclear function. Cell 92: 141-143, 1998.
6. Berger M, Stahl N, Del Sal G and Haupt Y: Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol Cell Biol 25: 5380-5388, 2005.
7. Albert A, Lavoie S and Vincent M: A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1. J Cell Sci 112: 2493-2500, 1999.
8. Liou YC, Ryo A, Huang HK, et al: Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA 99: 1335-1340, 2002.
9. Ryo A, Nakamura M, Wulf G, Liou YC and Lu KP: Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3: 793-801, 2001.
10. Yaffe MB, Schutkowski M, Shen M, et al: Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278: 1957-1960, 1997.
11. Zhou XZ, Kops O, Werner A, et al: Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 6: 873-883, 2000.
12. Fujimori F, Takahashi K, Uchida C and Uchida T: Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun 265: 658-663, 1999.
13. Maleszka R, Hanes SD, Hackett RL, de Couet HG and Miklos GL: The Drosophila melanogaster dodo (dod) gene, conserved in humans, is functionally interchangeable with the ESS1 cell division gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 93: 447-451, 1996.
14. Hsu T, McRackan D, Vincent TS and Gert de Couet H: Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nat Cell Biol 3: 538-543, 2001.
15. Wulf GM, Ryo A, Wulf GG, et al: Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 20: 3459-3472, 2001.
16. Miyashita H, Uchida T, Mori S, Echigo S and Motegi K: Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with cyclin D1 mRNA expression and clinical significance of cyclins. Oncol Rep 10: 1045-1048, 2003.
17. Lee JH, Song MY, Song EK, et al: Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 58: 344-351, 2009.
18. Ayala G, Wang D, Wulf G, et al: The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63: 6244-6251, 2003.
19. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP and Wang DG: Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164: 1727-1737, 2004.
20. Chen SY, Wulf G, Zhou XZ, Rubin MA, Lu KP and Balk SP: Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction. Mol Cell Biol 26: 929-939, 2006.
21. Fukuchi M, Fukai Y, Kimura H, et al: Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclin D1 expression. Int J Oncol 29: 329-334, 2006.
22. Kim CJ, Cho YG, Park YG, et al: Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression. World J Gastroenterol 11: 5006-5009, 2005.
23. Kokkinakis DM, Liu X and Neuner RD: Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Ther 4: 1338-1348, 2005.
24. Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H and Sugihara K: High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol 94: 155-160, 2006.
25. He J, Zhou F, Shao K, et al: Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer 56: 51-58, 2007.
26. Clurman BE and Roberts JM: Cell cycle and cancer. J Natl Cancer Inst 87: 1499-1501, 1995.
27. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
28. Jacks T and Weinberg RA: Cell-cycle control and its watchman. Nature 381: 643-644, 1996.
29. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ and Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20: 501-534, 1999.
30. Yeh ES, Lew BO and Means AR: The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J Biol Chem 281: 241-251, 2006.
31. Yeh E, Cunningham M, Arnold H, et al: A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6: 308-318, 2004.
32. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
33. Kim MR, Choi HK, Cho KB, Kim HS and Kang KW: Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells. Cancer Sci 100: 1834-1841, 2009.